- Paulson: U.S. Banking System Fundamentally Sound
- Dow Chemical, Kuwait Petroleum Base Venture In Michigan
- "Dark Knight" Brightens Hollywood With Best Weekend Ever
- Tomato Growers: Damage From Salmonella Scare Devastating
- Fed's Stern: Hike Rates Sooner Rather Than Later
- Bank Stocks: Fear Trumps Fundamentals
- Week's Rally Still Leaves Some on the Sidelines
- Stock Chatter Focuses on Financials, Pharma
- Freddie Mac Takes Step Toward Issuing Stock
- Web Extra: Your Earnings Edge And More
- Surprise Friday – Who Could It Be?
- The Latest Picks That Paid – Friday July 18th
- The Fast Money Misfires – Friday July 18th
- Pops & Drops: Intel, General Motors...
- The Future Of Wall Street
- Don’t Dump Everything Energy
- Can Apple Save Tech
- Kilduff: Iran Diplomacy = Lower Oil Prices?
Walgreen posted a 4.4 percent increase in sales at stores open at least a year as strong demand for Easter merchandise helped offset tepid sales growth for prescription drugs.
![]() |
Pharmacy same-store sales rose 0.8 percent, hurt by lower-priced generic drugs, a slower flu season and the switch of allergy medicine Zyrtec to over-the-counter status. The number of prescriptions filled at established stores fell 0.1 percent.
Same-store sales of general, or front-end, merchandise rose 11.3 percent, helped by the early Easter, which came in March this year and April last year.
Walgreen [WAG
Loading...
()
] and rival CVS Caremark [CVS
Loading...
()
], the two largest US drugstore operators, have seen sales of general merchandise hurt by the weak economy, but Walgreen said front-end sales in March exceeded expectations because of strong Easter sales.
Total sales rose 10.6 percent to $5.11 billion in March, the company said.
Walgreen shares edged up in premarket trading.






